Unrecognized Tax Benefits of Jazz Pharmaceuticals plc from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Jazz Pharmaceuticals plc quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Jazz Pharmaceuticals plc Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $143,022,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Jazz Pharmaceuticals plc Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $143,022,000 +$17,044,000 +14% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $125,978,000 +$3,284,000 +2.7% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $122,694,000 -$21,282,000 -15% 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q4 2022 $143,976,000 +$6,109,000 +4.4% 31 Dec 2022 10-K 24 Feb 2026 2025 FY
Q4 2021 $137,867,000 -$8,690,000 -5.9% 31 Dec 2021 10-K 26 Feb 2025 2024 FY
Q4 2020 $146,557,000 +$22,238,000 +18% 31 Dec 2020 10-K 28 Feb 2024 2023 FY
Q4 2019 $124,319,000 +$6,106,000 +5.2% 31 Dec 2019 10-K 01 Mar 2023 2022 FY
Q4 2018 $118,213,000 +$12,051,000 +11% 31 Dec 2018 10-K 01 Mar 2022 2021 FY
Q4 2017 $106,162,000 +$15,252,000 +17% 31 Dec 2017 10-K 23 Feb 2021 2020 FY
Q4 2016 $90,910,000 +$24,525,000 +37% 31 Dec 2016 10-K 25 Feb 2020 2019 FY
Q4 2015 $66,385,000 +$25,583,000 +63% 31 Dec 2015 10-K 26 Feb 2019 2018 FY
Q4 2014 $40,802,000 +$19,165,000 +89% 31 Dec 2014 10-K 27 Feb 2018 2017 FY
Q4 2013 $21,637,000 +$14,349,000 +197% 31 Dec 2013 10-K 28 Feb 2017 2016 FY
Q4 2012 $7,288,000 +$3,524,000 +94% 31 Dec 2012 10-K 23 Feb 2016 2015 FY
Q4 2011 $3,764,000 -$1,088,000 -22% 31 Dec 2011 10-K 24 Feb 2015 2014 FY
Q4 2010 $4,852,000 31 Dec 2010 10-K 25 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.